SMTL ID : 6c7r.1

BRD4 BD1 in complex with compound CF53

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x EO4: N-(3-cyclopropyl-1-methyl-1H-pyrazol-5-yl)-7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-4-amine(Non-covalent)

EO4.1: 12 residues within 4Å: Chain A: W.41, P.42, F.43, V.47, L.52, L.54, Y.57, C.96, N.100, D.105, I.106, M.109 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.41, A:F.43, A:V.47, A:L.52, A:L.52, A:L.54, A:D.105, A:I.106 Hydrogen bonds: A:P.42, A:N.100 Water bridges: A:Q.45, A:Q.45, A:Y.57 pi-Stacking: A:W.41

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhao, Y. et al., Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. J. Med. Chem. (2018)

Release Date

2018-08-01

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4